| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/09/2006 | DE102004031579A1 Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen Peptides to inhibit the interaction of protein kinase A and protein kinase A anchoring proteins |
| 02/09/2006 | DE10104721B4 Verfahren zur Erhöhung des Gehalts von Schwefelverbindungen in Pflanzen A method for increasing the content of sulfur compounds in plants |
| 02/09/2006 | CA2855056A1 A method of treating cancer comprising a vegf-b antagonist |
| 02/09/2006 | CA2834275A1 Method for isolation of transcription termination sequences |
| 02/09/2006 | CA2805455A1 Methods and compositions for modulating flowering and maturity in plants |
| 02/09/2006 | CA2762893A1 Method for isolation of transcription termination sequences |
| 02/09/2006 | CA2579790A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof |
| 02/09/2006 | CA2576093A1 Pharmaceutical compostion containing meltrin antagonist |
| 02/09/2006 | CA2576037A1 Method of producing glycoprotein composition |
| 02/09/2006 | CA2575986A1 Method of assuming drug sensitivity to cdk4 inhibitor |
| 02/09/2006 | CA2575898A1 Vaccine for prevention and treatment of hiv-infection |
| 02/09/2006 | CA2575875A1 Maltogenic alpha-amylase variants |
| 02/09/2006 | CA2575714A1 Yeast promoter |
| 02/09/2006 | CA2575552A1 Notch mutations leading to increased receptor signaling |
| 02/09/2006 | CA2575533A1 Site specific system for generating diversity protein sequences |
| 02/09/2006 | CA2575500A1 Monocot ahass sequences and methods of use |
| 02/09/2006 | CA2575480A1 Inducible gene expression |
| 02/09/2006 | CA2575433A1 Bacteria detection device, bacteria detection method and bacteria detection kit |
| 02/09/2006 | CA2575402A1 Humanized anti-cmet antagonists |
| 02/09/2006 | CA2575348A1 Novel anti-igf-ir antibodies and uses thereof |
| 02/09/2006 | CA2575140A1 Methods of isolating nucleic acids using multifunctional group-coated solid phase carriers |
| 02/09/2006 | CA2575127A1 Preparation of organisms with faster growth and/or higher yield |
| 02/09/2006 | CA2574791A1 Compositions and methods of using angiopoietin-like 4 protein |
| 02/09/2006 | CA2574770A1 Polypeptide |
| 02/09/2006 | CA2574593A1 Genetically modified host cells and use of same for producing isoprenoid compounds |
| 02/09/2006 | CA2574190A1 Use of apoptosis-specific eif-5a sirnas and antisense polynucleotides to inhibit/suppress an inflammatory response |
| 02/09/2006 | CA2573986A1 Transcription termination sequence and use thereof |
| 02/09/2006 | CA2573864A1 Immunoglobulins comprising predominantly a glcnacman5glcnac2 glycoform |
| 02/09/2006 | CA2573842A1 Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform |
| 02/09/2006 | CA2573554A1 Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
| 02/09/2006 | CA2573541A1 Immunoglobulins comprising predominantly a man3glcnac2 glycoform |
| 02/09/2006 | CA2573317A1 Method for production of transgenic plants with increased pathogenic resistance by altering the content and/or activity of actin-depolymerising factors |
| 02/09/2006 | CA2572294A1 Plant n-acylethanolamine binding proteins |
| 02/08/2006 | EP1624075A2 Detection of human papilloma virus |
| 02/08/2006 | EP1624068A1 Genetic immunization with cationic lipids |
| 02/08/2006 | EP1624067A2 Expression vectors containing hybrid ubiquitin promoters |
| 02/08/2006 | EP1624066A2 Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids |
| 02/08/2006 | EP1624065A2 Agarase and gene thereof |
| 02/08/2006 | EP1624064A2 Nucleic acids and proteins from streptococcus pneumoniae |
| 02/08/2006 | EP1624063A2 Chimeric gene encoding the antigenic determinants of four proteins of L. infantum |
| 02/08/2006 | EP1624062A2 Human 7tm proteins and polynucleotides encoding them |
| 02/08/2006 | EP1624061A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1624060A2 Control of gene expression |
| 02/08/2006 | EP1624059A2 Method of producing nucleic acid molecules with reduced secondary structure |
| 02/08/2006 | EP1624058A2 Methods and compositions for performing template dependent nucleic acid primer extension reactions that produce a reduced complexity product |
| 02/08/2006 | EP1624053A1 Substances for preventing and treating autoimmune diseases |
| 02/08/2006 | EP1624050A2 Multiply-substituted protease variants |
| 02/08/2006 | EP1623996A1 Improved method of selecting a desired protein from a library |
| 02/08/2006 | EP1623990A2 Compositions and methods for the treatment of tumours |
| 02/08/2006 | EP1623989A1 Compositions and methods for the diagnosis of tumours |
| 02/08/2006 | EP1623762A2 Cartridge for processing a nucleic acid sample |
| 02/08/2006 | EP1623046A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
| 02/08/2006 | EP1623039A2 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| 02/08/2006 | EP1623037A2 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicons vectors |
| 02/08/2006 | EP1623036A2 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2006 | EP1623035A1 Avian transgenesis using a chicken ovalbumin gene region |
| 02/08/2006 | EP1623034A2 Mechanisms of myoblast transfer in treating heart failure |
| 02/08/2006 | EP1623033A1 Process of producing a plastid-targeted protein in plant cells |
| 02/08/2006 | EP1623032A2 Small interfering rna libraries and methods of synthesis and use |
| 02/08/2006 | EP1623031A1 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar. |
| 02/08/2006 | EP1623029A1 Variant subtilisin enzymes (subtilases) |
| 02/08/2006 | EP1623025A1 Glucose dehydrogenase and production thereof |
| 02/08/2006 | EP1623016A2 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3 |
| 02/08/2006 | EP1623013A2 Methods for identification of coronaviruses |
| 02/08/2006 | EP1623012A2 ANTISENSE ANTIVIRAL AGENT AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
| 02/08/2006 | EP1623010A2 Preservation of rna in a biological sample |
| 02/08/2006 | EP1623009A2 Transfection kinetics and structural promoters |
| 02/08/2006 | EP1623008A2 Pufa polyketide synthase systems and uses thereof |
| 02/08/2006 | EP1623006A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 02/08/2006 | EP1622942A2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 02/08/2006 | EP1622938A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 02/08/2006 | EP1622937A2 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 02/08/2006 | EP1622936A1 Method for the production of an n-terminally modified chemotactic factor |
| 02/08/2006 | EP1622935A2 Spex compositions and methods of use |
| 02/08/2006 | EP1622934A2 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof |
| 02/08/2006 | EP1622921A2 Variants of beta-glucosidases |
| 02/08/2006 | EP1622638A2 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 02/08/2006 | EP1622635A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 02/08/2006 | EP1622634A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/08/2006 | EP1622626A1 Regulation of cell surface proteins |
| 02/08/2006 | EP1622597A2 Modulation of apolipoprotein c-iii expression |
| 02/08/2006 | EP1622574A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 02/08/2006 | EP1622572A2 Conjugates and compositions for cellular delivery |
| 02/08/2006 | EP1622571A2 Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |
| 02/08/2006 | EP1622570A2 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof |
| 02/08/2006 | EP1622566A2 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 02/08/2006 | EP1578974A4 Wound healing method and kits |
| 02/08/2006 | EP1539353B1 Slip cover for heated platen assembly |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1442126B1 Method for selecting genetically transformed cells |
| 02/08/2006 | EP1419274A4 Modular assembly of nucleic acid-protein fusion multimers |
| 02/08/2006 | EP1414998A4 Methods for the identification of inhibitors of ferredoxin nadp oxidoreductase expression or activity in plants |
| 02/08/2006 | EP1373569A4 Pcr method |
| 02/08/2006 | EP1337651B1 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1155148B1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis |
| 02/08/2006 | EP1133556B1 Root-preferred promoters and their use |
| 02/08/2006 | EP1114062B1 Modified e.coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1108058B1 Evolution of whole cells and organisms by recursive sequence recombination |